Lophos Holdings Inc.
Lophos Holdings Inc.
Lophos Holdings Inc. pertains to the cultivation and research of Lophophora williamsii (“peyote cactus”). Additionally, in the long-term, the Company is engaged in the research and development of compounds derived from peyote cactus. The company’s wholly-owned subsidiary, Lophos Pharmaceuticals Corp., is a biosciences company that specializes in peyote cactus cultivation, research, and sale. It is also licensed to possess, produce, sell/provide, send, transport and deliver the controlled substances covered by its Controlled Substances Dealers License (CSDL), namely mescaline, psilocin and psilocybin.
Lophos Holdings Inc. (MESC)
SEDAR Information
Company Info
Capitalization
Bulletins
2023-0827 - New Listing - Lophos Holdings Inc. (MESC)
le 31 août/August 2023
The common shares of Lophos Holdings Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.